The current tuberculosis (TB) vaccine Mycobacterium bovis bacillus Calmette-Guérin (BCG) is the most widely used vaccine worldwide, but it does not prevent the establishment of latent TB or ...

The bacillus Calmette–Guérin (BCG) vaccine, initially developed to provide protection against TB, also protects against leprosy; and the magnitude of this effect varies. Previous meta-analyses ...

Similar fears have also been voiced by suppliers in Japan, reporting a surge in demand for the BCG vaccine. The head of Iran's Revolutionary Guard Corps (IRGC) unveiled a hand-held device this ...

Administering the Bacillus Calmette-Guérin (BCG) vaccine during the active phase of COVID-19 may help protect against the development of long COVID. A phase 3 clinical trial initiated in early ...

BCG (Bacillus Calmette-Guerin) vaccine for tuberculosis, pictured at the Pasteur Institute in Paris in 1931. Scientists in the UK have begun testing the BCG vaccine, developed in 1921, to see if ...

Mention the word “BCG” and most Malaysians will recall (and probably shudder at the memory) the day they were jabbed with the ...